Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1999
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918855A1 Polycystic kidney disease gene
06/02/1999EP0918845A1 Cleavable signal element device and method
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
06/02/1999EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer
06/02/1999EP0918752A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0675729B1 ACTIVATION OF p53 PROTEIN
06/02/1999DE19756499A1 Microcapsules with porous membrane wall
06/02/1999CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908925 Genetically engineered immunoglobulins with specificity for glycated albumin
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908826 Freeze-dried preparation containing monoclonal antibody
06/01/1999US5908790 Methods for removing heavy metals from aqueous solutions and for analysis
06/01/1999US5908781 Hybridoma cell line producing antibodies; from immunization composition of desfuryol antibiotic conjugated to carrier through thio group
06/01/1999US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
06/01/1999US5908761 Sugar binding s-type lectin protein which has the ability to agglutinate formaldehyde-fixed, trypsin-treated rabbit erythrocytes; antiproliferative, antitumor, and anticarcinogenic agents
06/01/1999US5908757 Diagnosing by measuring complex formation of smooth muscle myosin heavy chain found in blood sample with specific antibodies; detecting increases levels
06/01/1999US5908756 Protein inhibitor of neuronal nitric oxide synthase
06/01/1999US5908627 Antigen associated with Type I diabetes mellitus
06/01/1999US5908626 Genetic engineering
06/01/1999CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus
06/01/1999CA1340568C Creatine kinase mb determination method
05/1999
05/27/1999WO1999026068A1 A method and device for preventing immunoglobulin degradation in external secretions
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025852A1 Stress resistance gene
05/27/1999WO1999025849A1 Single-chain bifunctional glycoprotein hormones
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025837A2 Method for producing virus-like particles on the basis of polyoma viruses
05/27/1999WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025831A2 Slit polypeptide and method of modulation of robo with ligands
05/27/1999WO1999025828A1 A human 2-19 protein homologue, z219c
05/27/1999WO1999025827A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999WO1999025826A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999WO1999025825A2 EXTENDED cDNAs FOR SECRETED PROTEINS
05/27/1999WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope
05/27/1999WO1999025817A2 Tc1-based transposon vectors
05/27/1999WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof
05/27/1999WO1999025739A1 Variable region fusion peptides that form effector complexes in the presence of antigen
05/27/1999WO1999025738A1 Detection of pr3-specific anti-neutrophil cytoplasmic autoantibodies in human serum
05/27/1999WO1999025737A1 Compositions and methods for treatment of autoimmune diseases, using a monoclonal antibody to the interleukin-12 beta2-chain
05/27/1999WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
05/27/1999WO1999025381A1 Linear antigen supporting units
05/27/1999WO1999025380A2 Methods and compositions for the treatment of psoriasis
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025375A2 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
05/27/1999WO1999025371A1 Novel molecules of the follistatin-related protein family and uses therefor
05/27/1999WO1999014357A3 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
05/27/1999WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999011660A3 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999CA2320399A1 A human 2-19 protein homologue, z219c
05/27/1999CA2310462A1 Linear antigen supporting units
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310215A1 Methods and compositions for the treatment of psoriasis
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309763A1 Variable region fusion peptides that form effector complexes in the presence of antigen
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309757A1 Stress resistance gene
05/27/1999CA2309387A1 Method and kit for determining severe inflammatory reactions to mosquito bites
05/27/1999CA2309343A1 Toso
05/27/1999CA2309336A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same
05/27/1999CA2309000A1 Tc1-based transposon vectors
05/27/1999CA2308571A1 Single-chain bifunctional glycoprotein hormones
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2302644A1 Extended cdnas for secreted proteins
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/26/1999EP0917878A1 Remedies for hepatitis
05/26/1999EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof
05/26/1999EP0917471A2 Treatment and diagnosis of infections of gram positive cocci
05/26/1999EP0741749B1 Mercury binding polypeptides and nucleotides coding therefor
05/26/1999EP0677117B1 Differentiation of htlv-i and htlv-ii using synthetic peptides
05/26/1999EP0635019B1 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0610290B1 Manufacture of a medicament for treatment of ocular inflammation by blockage of cell adhesion molecules
05/26/1999EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217791A Graphitic nanotubes in luminescence analysis
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217661A Method and composition for reconforming multi-epitopic antigens to initiate immune response
05/26/1999CN1217339A Cellulose binding domain
05/26/1999CN1217335A Method for preparing precursor medicine
05/25/1999US5907034 With same affinity to ethylenediamine tetraacetic acid and diethylenetriamine pentaacetic acid as to their complexes with manganese, cadmium, zinc, copper, yttrium, or lead
05/25/1999US5907033 Anti-oncostatin M monoclonal antibodies
05/25/1999US5907016 Method of coupling ligands onto supports and products produced therefrom
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906936 Endowing lymphocytes with antibody specificity
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999CA2216629A1 Enzyme system
05/25/1999CA1340557C Ckmb assay and monoclonal antibodies for use in same
05/20/1999WO1999024836A1 125 human secreted proteins
1 ... 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 ... 1494